Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

39 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication.
Loeppenthin K, Dalton SO, Johansen C, Andersen E, Christensen MB, Pappot H, Petersen LN, Thisted LB, Frølich A, Mortensen CE, Lassen U, Ørsted J, Bidstrup PE. Loeppenthin K, et al. Among authors: petersen ln. Br J Cancer. 2020 Sep;123(6):1033-1040. doi: 10.1038/s41416-020-0950-3. Epub 2020 Jul 7. Br J Cancer. 2020. PMID: 32632149
A Custom Genotyping Array Reveals Population-Level Heterogeneity for the Genetic Risks of Prostate Cancer and Other Cancers in Africa.
Harlemon M, Ajayi O, Kachambwa P, Kim MS, Simonti CN, Quiver MH, Petersen DC, Mittal A, Fernandez PW, Hsing AW, Baichoo S, Agalliu I, Jalloh M, Gueye SM, Snyper NYF, Adusei B, Mensah JE, Abrahams AOD, Adebiyi AO, Orunmuyi AT, Aisuodionoe-Shadrach OI, Nwegbu MM, Joffe M, Chen WC, Irusen H, Neugut AI, Quintana Y, Seutloali M, Fadipe MB, Warren C, Woehrmann MH, Zhang P, Ongaco CM, Mawhinney M, McBride J, Andrews CV, Adams M, Pugh E, Rebbeck TR, Petersen LN, Lachance J. Harlemon M, et al. Among authors: petersen ln. Cancer Res. 2020 Jul 1;80(13):2956-2966. doi: 10.1158/0008-5472.CAN-19-2165. Epub 2020 May 11. Cancer Res. 2020. PMID: 32393663
TAS-102 with or without bevacizumab in patients with chemorefractory metastatic colorectal cancer: an investigator-initiated, open-label, randomised, phase 2 trial.
Pfeiffer P, Yilmaz M, Möller S, Zitnjak D, Krogh M, Petersen LN, Poulsen LØ, Winther SB, Thomsen KG, Qvortrup C. Pfeiffer P, et al. Among authors: petersen ln. Lancet Oncol. 2020 Mar;21(3):412-420. doi: 10.1016/S1470-2045(19)30827-7. Epub 2020 Jan 27. Lancet Oncol. 2020. PMID: 31999946 Clinical Trial.
NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer.
Jensen LH, Olesen R, Petersen LN, Boysen AK, Andersen RF, Lindebjerg J, Nottelmann L, Thomsen CEB, Havelund BM, Jakobsen A, Hansen TF. Jensen LH, et al. Among authors: petersen ln. Cancers (Basel). 2019 Oct 25;11(11):1649. doi: 10.3390/cancers11111649. Cancers (Basel). 2019. PMID: 31731482 Free PMC article.
Safety and effectiveness of regorafenib in patients with metastatic colorectal cancer in routine clinical practice in the prospective, observational CORRELATE study.
Ducreux M, Petersen LN, Öhler L, Bergamo F, Metges JP, de Groot JW, Wang JY, García Paredes B, Dochy E, Fiala-Buskies S, Cervantes A, O'Connor JM, Falcone A; CORRELATE Investigators. Ducreux M, et al. Among authors: petersen ln. Eur J Cancer. 2019 Dec;123:146-154. doi: 10.1016/j.ejca.2019.09.015. Epub 2019 Nov 4. Eur J Cancer. 2019. PMID: 31698328 Free article. Clinical Trial.
Local recurrence rate in a national Danish patient cohort after curative treatment for rectal cancer.
Poulsen LØ, Yilmaz MK, Ljungmann K, Jespersen N, Wille-Jørgensen P, Petersen LN, Falkmer UG. Poulsen LØ, et al. Among authors: petersen ln. Acta Oncol. 2018 Dec;57(12):1639-1645. doi: 10.1080/0284186X.2018.1497299. Epub 2018 Aug 31. Acta Oncol. 2018. PMID: 30169998
Adjuvant FOLFOX +/- cetuximab in full RAS and BRAF wildtype stage III colon cancer patients.
Taieb J, Balogoun R, Le Malicot K, Tabernero J, Mini E, Folprecht G, Van Laethem JL, Emile JF, Mulot C, Fratté S, Levaché CB, Saban-Roche L, Thaler J, Petersen LN, Bridgewater J, Perkins G, Lepage C, Van Cutsem E, Zaanan A, Laurent-Puig P; PETACC8 Investigators. Taieb J, et al. Among authors: petersen ln. Ann Oncol. 2017 Apr 1;28(4):824-830. doi: 10.1093/annonc/mdw687. Ann Oncol. 2017. PMID: 28031175 Free article. Clinical Trial.
[The development of a generic guideline for multidisciplinary team conferences in Denmark].
Lajer H, Hillingsø J, Høyer S, Rasmussen TR, Hagemann-Madsen RH, Petersen LN, Dehn P, Borre M, Lundvall L. Lajer H, et al. Among authors: petersen ln. Ugeskr Laeger. 2016 Sep 26;178(39):V06160408. Ugeskr Laeger. 2016. PMID: 27697127 Danish.
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL, Thaler J, Bridgewater J, Petersen LN, Blons H, Collette L, Van Cutsem E, Rougier P, Salazar R, Bedenne L, Emile JF, Laurent-Puig P, Lepage C; PETACC-8 Study Investigators. Taieb J, et al. Among authors: petersen ln. Lancet Oncol. 2014 Jul;15(8):862-73. doi: 10.1016/S1470-2045(14)70227-X. Epub 2014 Jun 11. Lancet Oncol. 2014. PMID: 24928083 Free article. Clinical Trial.
Defence responses of Arabidopsis thaliana to infection by Pseudomonas syringae are regulated by the circadian clock.
Bhardwaj V, Meier S, Petersen LN, Ingle RA, Roden LC. Bhardwaj V, et al. Among authors: petersen ln. PLoS One. 2011;6(10):e26968. doi: 10.1371/journal.pone.0026968. Epub 2011 Oct 31. PLoS One. 2011. PMID: 22066021 Free PMC article.
39 results
Jump to page
Feedback